|Article title||PHYSICAL-CHEMICAL AND BIOLOGICAL PROPERTIES OF ULTRADISPERSED CRYSTALLINE FORMS I, II, III OF PIRACETAM|
|Authors||O.M. Kanunnikova, O.V. Karban, Yu.G. Vasilyev, V.V. Aksenova, V.V. Muhgalin, I.A. Volkhin, V.I. Ladyanov|
|Section||SECTION V. BIOMEDICAL NANOTECHNOLOGY|
|Month, Year||09, 2015 @en|
|Index UDC||615.011.3; 615.014.21|
|Abstract||Comparative studies of physical-chemical properties of crystal modifications of 2-oxo-1-pyrrolidineethanol, which is the group is the active substance of the drug piracetam, and the relationship of physical-chemical and biological properties of these modification. The change in the dispersion of the investigated modifications I, II, III implementation has been given by the method of ball milling. When used modes of ball milling was not observed degradation of piracetam and the formation of new chemical compounds. Solubility of piracetam the same for all the crystal modifications, the dependence of the water solubility from the dimensions of particles of powders of piracetam. The rate of dissolution increases with decreasing particle size of the powder decreases due to the formation of aggregates of small particles. The distribution coefficients in the system octanol-water (log P) the insignificant increase in the number of modifications are I< II < III. The coefficients of the distribution of ball milling modification II and modification III are almost identical. Pirate is there modification II has a higher biological activity in comparison with piracetam modification I. This property is manifested, first, in higher osmotic resistance of red blood cells in solutions of piracetam modification II and, secondly, more effective action of this modification of piracetam in acute ischemic response of the brain, mainly due to the protective response in the cell population. The cause of the observed effect is the formation of intramolecular hydrogen bonds in the molecule mechanically activated piracetam between NH2- and C=O groups, which leads to the increase of lipophilicity of piracetam and improve absorption by the body. Four months after mechanical activation of piracetam intramolecular hydrogen bond in the molecule modification II is destroyed, and biological activity of this modification becomes the same as for modification I.|
|Keywords||Piracetam; mechanical activation; particle size; solubility; distribution coefficient in the system octanol-water; biological activity.|
|References||1. Boldyrev V.V. Mekhanokhimiya i mekhanicheskaya aktivatsiya tverdykh veshchestv
[Mechanochemistry and mechanical activation of solids], Uspekhi khimii [Uspekhi Khimii],
2006, Vol. 75, No. 3, pp. 203-216.
2. Fundamental'nye osnovy mekhanicheskoy aktivatsii, mekhanosinteza i
mekhanokhimicheskikh tekhnologiy [Fundamental bases of mechanical activation,
mechanochemical mechanosynthesis and technology], ed. by Avvakumova E.G. Novosibirsk: Izd-vo SO RAN, 2009, 343 p.
3. Dubinskaya A.M. Mechanochemical transformations in organic substances, Chemistry Reviews, 1998, Vol. 23, pp. 201-261.
4. Lomovskiy O.I. Prikladnaya mekhanokhimiya: farmatsevtika i meditsinskaya promyshlennost' [Applied Mechanochemistry: pharmaceutics and medical industry], Obrabotka dispersnykh materialov i sred: Mezhd. periodicheskiy sb. nauchn. trudov [Processing of disperse materials and environments: an international periodical collection of scientific works], 2001, Issue 11, pp. 81-100.
5. Kanunnikova O.M., Mikhaylova S.S., Vol'khin I.A., Mukhgalin V.V., Aksenova V.V., Vasil'ev Yu.G., Berestov D.S., Lad'yanov V.I. Poluchenie, fiziko-khimicheskie i biologicheskie svoystva kristallicheskikh modifikatsiy piratsetama I i II [Obtaining, physico-chemical and biological properties of the crystalline modifications of the concentrations of I and II], Nauchnoe obozrenie [Science Review], 2015, No. 5, pp. 74-82.
6. Vasil'ev Yu.G., Vol'khin I.A., Berestov D.S., Kanunnikova O.M. Morfologicheskoe stroenie chernoy substantsii srednego mozga krys pri vvedenii razlichnykh form 2-okso-1-pirrolidinatsetamida na fone bilateral'noy okklyuzii obshchikh sonnykh arteriy [Morphological structure of the substantia nigra of the midbrain of rats at introduction of various forms of 2-oxo-1-pyrrolidineethanol on the background of bilateral occlusion of common carotid arteries], Fundamental'nye issledovaniya [Fundamental Research], 2014, No. 9, Part 8, pp. 1737-1741.
7. Fabbiani F.P.A., Allan D.R., Parsons S., Pulham C.R. An exploration of the polymorphism of piracetam using high pressure, Cryst. Eng. Comm., 2005, Vol. 7, No. 29, pp. 179-186.
8. Louer D., Louer M., Dzyabchenko V.A., Agafonov V., Ceolin R. Structure of a metastable phase of piracetam from X-ray powder diffraction using the atom-atom potential method, Acta Crystallographica. B, 1995, Vol. 51, pp. 182-187.
9. Admiraal G., Eikelenboom J.C., Vos A. Structures of the triclinic and monoclinic modifications of (2-ox0-1-pyrrolidinyl) acetamid, Acta Crystallographica B, 1982, Vol. 38, pp. 2600-2605.
10. Fabbiani F.P.A., Allan D.R., David W.I.F., Davidson A.J., Lennie A.R., Parsons S., Pulham C.R., Warren J.E. High-Pressure Studies of Pharmaceuticals: An Exploration of the Behavior of Piracetam, Cryst. Growth. Desig., 2007, Vol. 7, No. 6, pp. 1115-1124.
11. Kanunnikova O.M., Mikhaylova S.S., Karban' O.V., Mukhgalin V.V., Aksenova V.V., Sen'kovskiy B.V., Pechina E.A., Lad'yanov V.I. Vliyanie razlichnykh deformatsionnykh vozdeystviy na strukturno-khimicheskoe sostoyanie piratsetama [The influence of different deformation actions on the structural and chemical status of piracetam], Deformatsiya i razrushenie [Deformation and Destruction], 2015, No. 2, pp. 9-16.
12. Kanunnikova O.M., Pechina E.A., Vol'khin I.A., Mukhgalin V.V., Vasil'ev Yu.G., Lad'yanov V.I. Vliyanie vspomogatel'nykh veshchestv na fiziko-khimicheskie i biologicheskie svoystva piratsetama posle deformatsionnykh vozdeystviy [The influence of auxiliary substances on the physico-chemical and biological properties of piracetam after deformation effects], Nauka i obrazovanie [Science & Education], 2015, Vol. 12, No. 5, pp. 105-108.
13. Adamson A.W., Gast A.P. Physical Chemistry of Surfaces. New York: Wiley-Interscience Publications, 1997, 804 p.
14. Grassi M., Grassi G., Lapasin R., Colombo I. Understanding drug release and absorption mechanisms: A physical and mathematical approach. Boca Raton: CRC Press, 2007, pp. 29-248.
15. Grassi M., Colombo I., Lapasin R. Drug release from an ensemble of swellable crosslinked polymer particles, Journal of Controlled Release, 2000, Vol. 68, pp. 97-113.
16. Grassi M., Coceani N., Magarotto L. Effect of milling time on release kinetics from co-ground drug polymer systems, 2003 AAPS Annual Meeting and Exposition: Proceed. Salt lake City, 2003, M1201.
17. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Advanced Drug Delivery, Review Adv., 1997, Vol. 23, pp. 3-25.
18. Leo A., Hansch C., Elkins D. Partition coefficients and their uses, Chemical Reviews, 1971, Vol. 71, pp. 525-616.
19. Medic-Saric M., Mormar A.J.J.a. Lipophilicity study of salicylamide, Acta Pharmaceutica, 2004, No. 54, pp. 91-101.
20. Moridani M.Y., Galati G., O'Brien P.J. Comparative quantitative structure toxicity relation-ships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cell, Chemico-Biological Interaction, 2002, Vol. 139, No. 3, pp. 251-264.
21. Winblad B. Piracetam: a review of pharmacological properties and clinic uses CNS Drag Reviews, 2005, Vol. 11, pp.169-182.